These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 6496369

  • 1. Propafenone: noninvasive evaluation of efficacy.
    Podrid PJ, Cytryn R, Lown B.
    Am J Cardiol; 1984 Nov 14; 54(9):53D-59D. PubMed ID: 6496369
    [Abstract] [Full Text] [Related]

  • 2. Propafenone therapy for ventricular tachycardia in the setting of congestive heart failure.
    Brodsky MA, Allen BJ, Abate D, Henry WL.
    Am Heart J; 1985 Oct 14; 110(4):794-9. PubMed ID: 4050651
    [Abstract] [Full Text] [Related]

  • 3. Propafenone: a new agent for ventricular arrhythmia.
    Podrid PJ, Lown B.
    J Am Coll Cardiol; 1984 Jul 14; 4(1):117-25. PubMed ID: 6376591
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Propafenone treatment of recurrent ventricular tachycardia: comparison of continuous electrocardiographic recording and electrophysiologic study in predicting drug efficacy.
    Heger JJ, Hubbard J, Zipes DP, Miles WM, Prystowsky EN.
    Am J Cardiol; 1984 Nov 14; 54(9):40D-44D. PubMed ID: 6496368
    [Abstract] [Full Text] [Related]

  • 6. Propafenone for the treatment of refractory complex ventricular ectopic activity.
    Hammill SC, Sorenson PB, Wood DL, Sugrue DD, Osborn MJ, Gersh BJ, Holmes DR.
    Mayo Clin Proc; 1986 Feb 14; 61(2):98-103. PubMed ID: 3945115
    [Abstract] [Full Text] [Related]

  • 7. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
    Coumel P, Leclercq JF, Assayag P.
    Am J Cardiol; 1984 Nov 14; 54(9):60D-66D. PubMed ID: 6208770
    [Abstract] [Full Text] [Related]

  • 8. Aggravation of electrically provoked ventricular tachycardia during treatment with propafenone.
    Stavens CS, McGovern B, Garan H, Ruskin JN.
    Am Heart J; 1985 Jul 14; 110(1 Pt 1):24-9. PubMed ID: 4013986
    [Abstract] [Full Text] [Related]

  • 9. Propafenone in the treatment of patients with malignant ventricular tachyarrhythmias.
    Kowey PR, Stohler JL, Friehling TD, Marinchak RA.
    Can J Cardiol; 1991 May 14; 7(4):175-80. PubMed ID: 2070286
    [Abstract] [Full Text] [Related]

  • 10. Propafenone for refractory ventricular arrhythmias: correlation with drug plasma levels during long-term treatment.
    Naccarella F, Bracchetti D, Palmieri M, Marchesini B, Ambrosioni E.
    Am J Cardiol; 1984 Nov 01; 54(8):1008-14. PubMed ID: 6496321
    [Abstract] [Full Text] [Related]

  • 11. [Therapy of ventricular tachyarrhythmias refractory to lidocaine with propafenone (author's transl)].
    Laimer H, Glogar D, Zilcher H.
    Acta Med Austriaca; 1981 Nov 01; 8(5):140-4. PubMed ID: 7331741
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of recurrent ventricular tachycardias using oral propafenone].
    Cointe R, Lévy S, Metge M, Vrancea F, Labrunie P, Valeix B, Gérard R.
    Arch Mal Coeur Vaiss; 1985 Oct 01; 78 Spec No():59-62. PubMed ID: 3938260
    [Abstract] [Full Text] [Related]

  • 13. Limited role of intravenous propafenone hydrochloride in the treatment of sustained ventricular tachycardia: electrophysiologic effects and results of programmed ventricular stimulation.
    Doherty JU, Waxman HL, Kienzle MG, Cassidy DM, Marchlinski FE, Buxton AE, Josephson ME.
    J Am Coll Cardiol; 1984 Aug 01; 4(2):378-81. PubMed ID: 6736479
    [Abstract] [Full Text] [Related]

  • 14. Antiarrhythmic and electrophysiologic effects of oral propafenone.
    Prystowsky EN, Heger JJ, Chilson DA, Miles WM, Hubbard J, Zipes DP.
    Am J Cardiol; 1984 Nov 14; 54(9):26D-28D. PubMed ID: 6496366
    [Abstract] [Full Text] [Related]

  • 15. Electrophysiologic effects and clinical efficacy of oral propafenone therapy in patients with ventricular tachycardia.
    Chilson DA, Heger JJ, Zipes DP, Browne KF, Prystowsky EN.
    J Am Coll Cardiol; 1985 Jun 14; 5(6):1407-13. PubMed ID: 3889099
    [Abstract] [Full Text] [Related]

  • 16. Acute and long-term efficacy of oral propafenone in patients with ventricular tachyarrhythmias.
    Budde T, Borggrefe M, Podczeck A, Martinez-Rubio A, Breithardt G.
    J Cardiovasc Pharmacol; 1991 Aug 14; 18(2):254-60. PubMed ID: 1717787
    [Abstract] [Full Text] [Related]

  • 17. Predictors of antiarrhythmic drug efficacy in patients with malignant ventricular tachyarrhythmias.
    Hohnloser SH, Raeder EA, Podrid PJ, Graboys TB, Lown B.
    Am Heart J; 1987 Jul 14; 114(1 Pt 1):1-7. PubMed ID: 3604854
    [Abstract] [Full Text] [Related]

  • 18. [Comparative study on the efficacy of disopyramide and propafenone in the prevention of the recurrence of ventricular tachycardia].
    Palmieri M, Capucci A, Lombardi G, Naccarella F, Bomba E, Bracchetti D.
    G Ital Cardiol; 1984 May 14; 14(5):357-9. PubMed ID: 6468817
    [Abstract] [Full Text] [Related]

  • 19. Antiarrhythmic efficacy and hemodynamic effects of cibenzoline in patients with nonsustained ventricular tachycardia and left ventricular dysfunction.
    Seals AA, Haider R, Leon C, Francis M, Young JB, Roberts R, Pratt CM.
    Circulation; 1987 Apr 14; 75(4):800-8. PubMed ID: 3549044
    [Abstract] [Full Text] [Related]

  • 20. Acute and long-term efficacy of propafenone in patients with sustained ventricular tachyarrhythmias: assessment with programmed ventricular stimulation.
    Podczeck A, Frohner K, Hief C, Stix G, Steinbach KK.
    Eur Heart J; 1991 Jul 14; 12(7):796-9. PubMed ID: 1889445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.